{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T22:15:53Z","timestamp":1788041753127,"version":"build-2784847793"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijcrp.2026.200701","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:01:48Z","timestamp":1787389308000},"page":"200701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Gaps and disparities in Lp(a) testing before universal screening: A 10-year analysis"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4375-0891","authenticated-orcid":false,"given":"Hemchandra B.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Bawahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5447-8091","authenticated-orcid":false,"given":"Vlad C.","family":"Vasile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijcrp.2026.200701_bib1","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American heart association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200701_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/eci.70133","article-title":"The biology of lipoprotein(a): from genetics to molecular mechanisms","volume":"56","author":"Atallah","year":"2026","journal-title":"Eur. J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200701_bib3","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.3390\/ijms25063537","article-title":"Lipoprotein(a) and atherosclerotic cardiovascular disease: where do we stand?","volume":"25","author":"Tsioulos","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ijcrp.2026.200701_bib4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jacc.2021.12.016","article-title":"Managing atherosclerotic cardiovascular risk in young adults: JACC state-of-the-art review","volume":"79","author":"Stone","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcrp.2026.200701_bib5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/phar.2851","article-title":"Role of lipoprotein(a) in atherosclerotic cardiovascular disease: a review of current and emerging therapies","volume":"43","author":"Alhomoud","year":"2023","journal-title":"Pharmacotherapy"},{"issue":"11 Pt 1","key":"10.1016\/j.ijcrp.2026.200701_bib6","article-title":"Lipoprotein(a) testing trends in the United States 2015-2024: an analysis of 300 million individuals","volume":"4","author":"Ramsis","year":"2025","journal-title":"JACC Adv"},{"issue":"18","key":"10.1016\/j.ijcrp.2026.200701_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031255","article-title":"Lipoprotein(a) testing trends in a large academic health system in the United States","volume":"12","author":"Bhatia","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcrp.2026.200701_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100686","article-title":"Testing practices and clinical management of lipoprotein(a) levels: a 5-year retrospective analysis from the johns hopkins Hospital","volume":"19","author":"Eidensohn","year":"2024","journal-title":"Am. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcrp.2026.200701_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ahj.2025.06.010","article-title":"Global lipoprotein (a) testing trends from 2015 to 2023","volume":"289","author":"Hanif","year":"2025","journal-title":"Am. Heart J."},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200701_bib10","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamacardio.2022.0987","article-title":"Lipoprotein(a) and its significance in cardiovascular disease: a review","volume":"7","author":"Duarte","year":"2022","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcrp.2026.200701_bib11","unstructured":"Donato LJ, Weintraub HS. Lp(A) in Practice: Challenges in Testing and Opportunities in Care. n.d."},{"issue":"9","key":"10.1016\/j.ijcrp.2026.200701_bib12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/CIRCULATIONAHA.124.070361","article-title":"Prevalence of Lipoprotein(a) testing in a contemporary cohort","volume":"151","author":"Bansal","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2026.200701_bib13","doi-asserted-by":"crossref","unstructured":"Writing Committee Members, Blumenthal RS, Morris PB et al. 2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of dyslipidemia: a report of the American college of Cardiology\/American Heart Association Joint Committee on clinical practice Guidelines. Circulation n.d.;0(0). https:\/\/doi.org\/10.1161\/CIR.0000000000001423.","DOI":"10.1161\/CIR.0000000000001423"},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200701_bib14","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCULATIONAHA.124.069210","article-title":"Lipoprotein(a) as a pharmacological target: premises, promises, and prospects","volume":"151","author":"Greco","year":"2025","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ijcrp.2026.200701_bib15","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1615758","article-title":"Inclisiran in patients at high cardiovascular risk with elevated LDL cholesterol","volume":"376","author":"Ray","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ijcrp.2026.200701_bib16","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1001\/jama.2023.21835","article-title":"Lepodisiran, an extended-duration short interfering RNA targeting Lipoprotein(a): a randomized dose-ascending clinical trial","volume":"330","author":"Nissen","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200701_bib17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"17_supplement_2","key":"10.1016\/j.ijcrp.2026.200701_bib18","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1212\/WNL.0000000000202625","article-title":"Clinical characteristics of early-onset parkinson disease in Mayo Clinic population (P6-11.004)","volume":"100","author":"Ghoniem","year":"2023","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ijcrp.2026.200701_bib19","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1097\/DCR.0000000000003466","article-title":"Comparative outcomes of robotic versus open proctectomy for rectal cancer at high risk of positive circumferential resection Margin","volume":"67","author":"Cardelli","year":"2024","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.ijcrp.2026.200701_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100886","article-title":"Lipoprotein (a) testing patterns among subjects with a measured lipid panel: the Mayo Clinic experience","volume":"20","author":"Manzato","year":"2024","journal-title":"Am. J. Prev. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200701_bib21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jacl.2019.04.010","article-title":"Use of Lipoprotein(a) in clinical practice: a biomarker whose time has come. A scientific statement from the National Lipid Association","volume":"13","author":"Wilson","year":"2019","journal-title":"J. Clin. Lipidol."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200701_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2017.11.014","article-title":"NHLBI Working Group recommendations to reduce Lipoprotein(a)-Mediated risk of cardiovascular disease and aortic stenosis","volume":"71","author":"Tsimikas","year":"2018","journal-title":"JACC (J. Am. Coll. Cardiol.)"},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200701_bib23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1194\/jlr.R061648","article-title":"Lipoprotein (a) measurements for clinical application","volume":"57","author":"Marcovina","year":"2016","journal-title":"JLR (J. Lipid Res.)"},{"issue":"39","key":"10.1016\/j.ijcrp.2026.200701_bib24","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2026.200701_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.101402","article-title":"Trends in lipoprotein(a) testing and impact on clinical care: a contemporary systemwide analysis","volume":"25","author":"Mangla","year":"2026","journal-title":"Am. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcrp.2026.200701_bib26","article-title":"Cardiovascular disease in women: traditional and sex-specific risk factors","volume":"4","author":"Appelman","year":"2025","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.ijcrp.2026.200701_bib27","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/jamacardio.2025.1603","article-title":"AHA PREVENT equations and Lipoprotein(a) for cardiovascular disease risk : insights from MESA and the UK biobank","volume":"10","author":"Bhatia","year":"2025","journal-title":"JAMA Cardiol."},{"issue":"11, Part 1","key":"10.1016\/j.ijcrp.2026.200701_bib28","article-title":"Elevated Lipoprotein(a) independently increases risk for short-term atherosclerotic cardiovascular events in machine learning predictive models","volume":"4","author":"Ward","year":"2025","journal-title":"JACC (J. Am. Coll. Cardiol.): Advances"}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487526001315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487526001315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T21:39:28Z","timestamp":1788039568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487526001315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":28,"alternative-id":["S2772487526001315"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2026.200701","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gaps and disparities in Lp(a) testing before universal screening: A 10-year analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2026.200701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200701"}}